Subsense Secures $27M Seed Funding for Nanoparticle BCI
Subsense has raised $27 million in seed funding to develop a nanoparticle-based brain-computer interface. This technology aims to provide a less invasive alternative to current methods for treating neurological disorders.
Summaries are written by AI from the original article. Not investment advice.